Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool

Vicente Herrero‐Aguayo(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Raúl M. Luque(Instituto de Salud Carlos III), Aura D. Herrera‐Martínez(Instituto Maimónides de Investigación Biomédica de Córdoba), Manuel D. Gahete(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), María Trinidad Moreno-Montilla(Instituto Maimónides de Investigación Biomédica de Córdoba), Francisco Porcel-Pastrana(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Prudencio Sáez-Martínez(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Julia Carrasco‐Valiente(Instituto Maimónides de Investigación Biomédica de Córdoba), Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), André Sarmento‐Cabral(University of Illinois Chicago), Antonio J. Montero‐Hidalgo(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Francisco J. Anglada(Instituto Maimónides de Investigación Biomédica de Córdoba), Jesús M. Pérez‐Gómez(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Juan L López-Cánovas(Instituto Maimónides de Investigación Biomédica de Córdoba), Enrique Gómez‐Gómez(Instituto Maimónides de Investigación Biomédica de Córdoba), Juan M. Jiménez-Vacas(Institute of Cancer Research), Elena M. Yubero‐Serrano(Unknown)
Molecular Therapy — Nucleic Acids
February 12, 2022
Cited by 11


Related Papers